In line with the pieces of evidence showing the involvement of the EC system in the regulation of inflammation and GI function, our findings of the upregulation of CB1R and CB2R in rats fed a KD suggest that the manipulation of the EC system signaling pathway can be considered an effective strategy in IBS treatment. The gene discussed is CNR1; the disease is irritable bowel syndrome.